The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...
The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...
Finding out how microbes make compounds containing the diazo chemical group could help researchers to synthesize useful ...
AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.
As a range of new artificial intelligence startups over the past two years have launched their own search engines, such as ...
Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...
Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry - to deploy secure, on-premises AI systems directly within client environments where propriet ...
While regulatory alignment remains essential, operational urgency driving companies to AI adoption is equally profound. In ...
Comprising 1,016 Nvidia Blackwell Ultra GPUs, the SuperPOD offers more than 9,000 petaflops of AI performance and will be used to train biomedical foundation and frontier models, reducing drug ...
The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...
A Cardiff-based artificial intelligence-driven Techbio company has secured a joint equity investment to accelerate its drug discovery work and create jobs.
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results